NCT00366301 The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE4
NCT00362765 Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study Status TERMINATED Phase PHASE2/PHASE3
NCT00362323 Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO Status COMPLETED Phase PHASE3
NCT00359112 AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00358124 Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy Status COMPLETED Phase PHASE4
NCT00353691 Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00350779 Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) Status COMPLETED Phase PHASE3
NCT00348712 Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT00333151 Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00331851 Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00328172 Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients Status COMPLETED Phase PHASE2
NCT00327015 A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Status COMPLETED Phase PHASE3
NCT00325910 Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study Status TERMINATED Phase PHASE3
NCT00319293 Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome Status UNKNOWN Phase NA
NCT00318461 To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together Status COMPLETED Phase PHASE3
NCT00316758 A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes. Status COMPLETED Phase PHASE2
NCT00316082 Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise Status COMPLETED Phase PHASE3